General MedicationsORALStandard
VIGAFYDE
VIGABATRIN
Standard Dose
100MG/ML
Max Dose
Refer to approved labeling
Primary Use
Review priority: N/A Marketing status: Prescription
Summary
Approval overview VIGAFYDE is listed in Drugs@FDA under application 217684 (NDA).
Review priority: N/A Marketing status: Prescription Active ingredient VIGABATRIN Form and strength SOLUTION;ORAL - 100MG/ML Sponsor PYROS PHARMS Submission history Latest submission status date: 2026-03-18 00:00:00.
Structured Monograph
Clinical summary
Approval overview VIGAFYDE is listed in Drugs@FDA under application 217684 (NDA). Review priority: N/A Marketing status: Prescription Active ingredient VIGABATRIN Form and strength SOLUTION;ORAL - 100MG/ML Sponsor PYROS PHARMS Submission history Latest submission status date: 2026-03-18 00:00:00. Submission type: SUPPL.
Monitoring
- • Marketing status: Prescription
- • Review priority: N/A
Interaction Notes
- No interaction notes stored yet.